United States · FDA National Drug Code directory
SEVOFLURANE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10019-653_e04090f9-97a3-4fe5-9bc1-c4a86ac9a6a1
- Product NDC
- 10019-653
- Form
- LIQUID
- Composition / generic term
- Sevoflurane
- Labeler
- Baxter Healthcare Corporation
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20020707
- Source listing expiry
- 20271231
Source-listed ingredients
- SEVOFLURANE — 250 mL/250mL
These values do not establish equivalence or a dose recommendation.
Packages
- 6 BOTTLE in 1 CARTON (10019-653-64) / 250 mL in 1 BOTTLE · 10019-653-64
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →